NCT00419328 2022-07-21
A Modified Phase I Study of NGR-hTNF in Advanced Solid Tumors
AGC Biologics S.p.A.
Phase 1 Completed
AGC Biologics S.p.A.
AGC Biologics S.p.A.
AGC Biologics S.p.A.
European Organisation for Research and Treatment of Cancer - EORTC